Lophora Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Later Stage VC
- (In Progress)
- Latest Deal Amount
-
$15M
- Investors
-
6
Lophora General Information
Description
Developer of next-generation neuroactive medicines designed to induce neuroplasticity and address unmet needs in neuropsychiatric disorders. The company offers an oral clinical-stage 5-HT2A therapy designed for at-home use, enabling neuropsychiatric patients to access treatments without the need for psychedelic-assisted treatment infrastructure.
Contact Information
Website
www.lophora.comCorporate Office
- Herlev Hovedhade 195A
- Greater Copenhagen Area
- 2730 Herlev
- Denmark
Corporate Office
- Herlev Hovedhade 195A
- Greater Copenhagen Area
- 2730 Herlev
- Denmark
Lophora Timeline
Lophora Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 11-Aug-2026 | $15M | In Progress | Clinical Trials - Phase 1 | ||
| 6. Later Stage VC | 15-Jan-2025 | Completed | Clinical Trials - Phase 1 | |||
| 5. Later Stage VC | 24-Aug-2023 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 23-Nov-2020 | Completed | Startup | |||
| 3. Accelerator/Incubator | 03-Apr-2020 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2019 | $152K | $152K | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2018 | Completed | Startup |
Lophora Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 1,046 | $47 | $47 | 1x | $47 | 1.65% | ||
| Ordinary | 2,519 | $12.61 | $12.61 | 1x | $12.61 | 3.98% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Lophora Patents
Lophora Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-7880894-B2 | (s)-3-(2,5-dimethoxy-4-(trifluoromethyl)phenyl)piperidine and (s)-3-(2-methoxy-5-(methylthio)-4-(trifluoromethyl)phenyl)piperidine acid addition salts, specific polymorphs thereof, and methods for producing them. | Active | 06-May-2021 | ||
| JP-2024519457-A | Acid addition salts of (s)-3-(2,5-dimethoxy-4-(trifluoromethyl)phenyl)piperidine and (s)-3-(2-methoxy-5-(methylthio)-4-(trifluoromethyl)phenyl)piperidine, certain polymorphs thereof and methods for preparing them | Active | 06-May-2021 | ||
| CA-3216083-A1 | Acid addition salts of (s)-3-(2,5-dimethoxy-4-(trifluoromethyl)phenyl)piperidine and (s)-3-(2-methoxy-5-(methylthio)-4-(trifluoromethyl)phenyl)piperidine, specific polymorphs thereof and methods for their manufactur | Pending | 06-May-2021 | ||
| AU-2022270930-A1 | Acid addition salts of (s)-3-(2,5-dimethoxy-4-(trifluoromethyl)phenyl)piperidine and (s)-3-(2-methoxy-5-(methylthio)-4-(trifluoromethyl)phenyl)piperidine, specific polymorphs thereof and methods for their manufacture | Pending | 06-May-2021 | ||
| EP-4334288-A1 | Acid addition salts of (s)-3-(2,5-dimethoxy-4-(trifluoromethyl)phenyl)piperidine and (s)-3-(2-methoxy-5-(methylthio)-4-(trifluoromethyl)phenyl)piperidine, specific polymorphs thereof and methods for their manufacture | Pending | 06-May-2021 | C07D211/02 |
Lophora Signals
Lophora Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BNC Korea | Corporation | Minority | ||
| Mystic Ventures | Venture Capital | Minority | ||
| Innovationsfonden | Accelerator/Incubator | Minority | ||
| Novo Nordisk | Corporation | Minority | ||
| BioInnovation Institute | Accelerator/Incubator | Minority |
Lophora FAQs
-
When was Lophora founded?
Lophora was founded in 2018.
-
Where is Lophora headquartered?
Lophora is headquartered in Herlev, Denmark.
-
What is the size of Lophora?
Lophora has 7 total employees.
-
What industry is Lophora in?
Lophora’s primary industry is Drug Delivery.
-
Is Lophora a private or public company?
Lophora is a Private company.
-
What is the current valuation of Lophora?
The current valuation of Lophora is .
-
What is Lophora’s current revenue?
The current revenue for Lophora is .
-
How much funding has Lophora raised over time?
Lophora has raised $5.56M.
-
Who are Lophora’s investors?
BNC Korea, Mystic Ventures, Innovationsfonden, Novo Nordisk, and BioInnovation Institute are 5 of 6 investors who have invested in Lophora.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process